This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Breast Cancer
and you are
over 21
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

There are no data regarding the use of supplements to alleviate the musculoskeletal pain and stiffness inducted by the use of aromatase inhibitors. This study is designated to test the safety and efficacy of omega 3 fatty acid supplementation to alleviate musculoskeletal pain in postmenopausal breast cancer patients.

Provided treatments

  • : Omega-3 Fatty Acid
Tris trial is registered with FDA with number: NCT00930527. The sponsor of the trial is Columbia University and it is looking for 10 volunteers for the current phase.
Official trial title:
Randomized Phase II Study of Omega-3-Fatty Acid on Joint Symptoms Induced by Aromatase Inhibitors in Breast Cancer Patients